首页> 外国专利> GENETIC PRODUCTS DIFFERENTIALLY EXPRESSED IN CANCEROSE CHEST CELLS AND THEIR METHODS OF USE.

GENETIC PRODUCTS DIFFERENTIALLY EXPRESSED IN CANCEROSE CHEST CELLS AND THEIR METHODS OF USE.

机译：在癌性胸腺细胞中差异表达的基因产物及其使用方法。

页面导航

摘要
著录项
相似文献

摘要

Use of an agent selected from the group consisting of an antibody, a complementary polynucleotide and an RNAi molecule based on the polynucleotide of DKFZp566I133 or a corresponding polypeptide for the inhibition of the activity of DKFZp566I133, to prepare a pharmaceutical composition to inhibit a cancerous phenotype of a breast cell.

机译：选自抗体，互补多核苷酸和基于DKFZp566I133的多核苷酸或相应多肽的RNAi分子的试剂在抑制DKFZp566I133的活性中的用途，用于制备抑制肿瘤的癌表型的药物组合物。乳腺细胞。

著录项

公开/公告号ES2323456T3

专利类型
公开/公告日2009-07-16

原文格式PDF
申请/专利权人 NOVARTIS VACCINES AND DIAGNOSTICS INC.;
展开▼

申请/专利号ES20030729383T
发明设计人 HANSEN RHONDA;
展开▼

申请日2003-01-08
分类号C12Q1/68;G01N33/53;A01N43/04;A61K31/07;A61K31/7088;A61K31/7105;A61K38;A61K39/395;A61K45;A61K48;A61P35;C07H21/04;C07K14/47;C12N5/06;C12N15/09;C12Q1/02;G01N33/566;
国家 ES
入库时间 2022-08-21 19:23:46

相似文献

专利
外文文献
中文文献